Camtek Ltd.CAMT
NASDAQ • Technology
$166.07
P/E
149.61
PEG
17.20
FCF Yield
—
Rev Growth YoY
+9.2% YoY
Gross Margin
50.0%
Health Score
7/10
D/E Ratio
0.84
Confidence
LOW
Business Snapshot
Camtek Ltd. provides inspection and metrology solutions for the semiconductor industry, focusing on advanced packaging, memory, and CMOS image sensors. The company competes in a niche segment of semiconductor capital equipment, serving customers that require precision inspection systems for wafer-level and die-level processes. With trailing twelve-month revenue of $496.07 million, it operates as a mid-sized player in the semiconductor equipment space. One defining characteristic is its reliance on the cyclical semiconductor capital spending cycle, which makes revenue growth sensitive to industry investment trends.
Financial Health
Gross margin stands at 50.0%, unchanged from the prior year, while net margin (TTM) is reported at -6.8% — a figure that contradicts the positive TTM net income of $50.72 million and may reflect a data anomaly or non-recurring charge. The balance sheet is healthy: debt/equity of 0.84x is moderate and the current ratio of 8.35x indicates substantial short-term liquidity...
Risk Assessment
- VALUATION — P/E of 149.61x versus the sector average of 35x implies a substantial premium that leaves little room for error.
- EARNINGS QUALITY — Only 2 of the last 4 quarters beat analyst estimates, indicating mediocre earnings predictability.
- REVENUE DECELERATION — While YoY revenue growth is 9.2%, sequential growth is just 1.7%, suggesting a potential slowdown in the latest quarter’s pace.
- 52-WEEK POSITION — The current price of $166.07 is closer to the 52-week high of $215.99 than the low of $62.88, but still 23% below the high, leaving downside risk if momentum fades.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- VALUATION DIVERGENCE — The FMP DCF fair value of $37.31 implies extreme overvaluation, but the Python DCF could not be calculated due to negative or unavailable FCF, introducing uncertainty about intrinsic value....